Strattera 300mg capsule contains the active ingredient Strattera. It belongs to the class of non-benzodiazepine ADHD medications and works by increasing levels of norepinephrine in the brain. This increases focus and helps to improve executive functions such as impulse control, planning, and decision-making. It is a common ADHD treatment, with many studies showing effectiveness in reducing symptoms.
Indications: Strattera is used to treat attention deficit hyperactivity disorder (ADHD). This medication belongs to the class of medications known as selective norepinephrine reuptake inhibitors (SNRIs).
Dosage: The recommended dose is usually 50 mg once daily. Dosage may change occasionally due to side effects. This medicine can be taken with or without food, but consistency is key. Taking the lowest dose for the shortest duration can help to reduce your dose and maximize its effectiveness.
Warnings: Do not take this medication if you have severe heart or liver problems, have recently had a stroke or heart attack, have low blood pressure, have severe mental or mood problems, have recently experienced a stroke or heart attack, or have a history of suicidal thoughts or behavior. Tell your doctor right away if you notice any of the following symptoms during or after your treatment: agitation, restlessness, confusion, muscle weakness, tremors, rapid heartbeat, loss of consciousness, seizures, or severe dizziness. These symptoms may also appear within the first few days of starting treatment and may require maximum of 6 sessions.
Talk to your doctor before taking this medicine if you have:
Taking this medication with food may help to reduce the chances of side effects. However, consistency is key for optimal effectiveness.
: Do not take Strattera 300mg capsule if:
Children and adolescents:The safety and effectiveness of Strattera in children and adolescents have not been established. However, it is thought to be effective in children and adolescents aged 12-17 years when used at a dose of 300mg daily. This medication should be used only under the guidance and supervision of a doctor.
Strattera Atomoxetine may be given by your doctor, or may be prescribed by your healthcare provider.
Strattera atomoxetine is available in the United States under a variety of brand names including Strattera, Atomoxetine, Strattera, and Adderall. Each brand of Strattera atomoxetine contains the active ingredient atomoxetine. It is used to treat attention deficit hyperactivity disorder (ADHD) in children ages 5 years and older. In adults, Strattera atomoxetine belongs to a class of drugs known as selective norepinephrine reuptake inhibitors (SNRIs). Strattera atomoxetine is used to treat attention deficit hyperactivity disorder (ADHD) in children ages 5 years and older. The recommended dosage of Strattera atomoxetine varies depending on the condition being treated. Dosage adjustments may be made depending on individual response to treatment and the patient's age.
Your healthcare provider will determine the appropriate dosage of Strattera atomoxetine based on your specific symptoms and medical condition. Strattera atomoxetine should be swallowed whole and not crushed or chewed.
If you have any questions about using Strattera atomoxetine please talk to your doctor or pharmacist. Do not share this medication with others.
If you are using the atomoxetine combination for treating attention deficit hyperactivity disorder (ADHD), your doctor may suggest a different medication for that matter or a combination medication that treats both conditions simultaneously. Your doctor may have specific questions about the appropriate dosage of Strattera atomoxetine based on your symptoms and medical condition. Your doctor will determine which treatment is best for you.
Your doctor will discuss with you the risks and benefits of Strattera atomoxetine treatment based on your symptoms and medical condition. They may monitor your condition and may adjust the dosage of Strattera atomoxetine based on your symptoms and medical condition.
Strattera atomoxetine can cause side effects in some people. Tell your doctor if any of these rare side effects or any other concerns about your treatment are experienced or bother you:
Tell your doctor if you notice any changes in your behavior, thoughts, or feelings, including suicidal thoughts, while using Strattera atomoxetine.
Strattera atomoxetine is not recommended for use in children under 5 years of age because it can cause problems in coordination, trouble breathing, or swelling of the ankles, feet, or legs.
Before taking Strattera atomoxetine, tell your doctor about all of your medical conditions.
If you are using the atomoxetine combination for treating ADHD, your doctor will determine whether Strattera atomoxetine is right for you based on your symptoms and medical condition. Your doctor will talk to you about the pros and cons of Strattera atomoxetine treatment based on your symptoms and medical condition.
Your doctor may monitor your condition and may adjust the dosage of Strattera atomoxetine based on your symptoms and medical condition. Your doctor will also talk to you about the risks and benefits of Strattera atomoxetine treatment based on your symptoms and medical condition.
It is not known whether Strattera atomoxetine passes into breast milk or if it could harm your infant. Strattera atomoxetine can pass into breast milk and may be affected by the milk. If you are breastfeeding, talk to your doctor about how you can get Strattera atomoxetine for your baby.
Strattera atomoxetine is not recommended for use in children under 5 years of age.
During treatment with Strattera atomoxetine, your doctor will check your progress and follow-up lab tests as directed.
Drug-related adverse events reported during the initiation of Strattera therapy were evaluated for safety and frequency of occurrence. The reported events were classified into three categories:
The first event was defined as any of the following:
The most common adverse event reported in the initiation of Strattera therapy was headache, which was reported in 1% of patients who received Strattera tablets. The most commonly reported adverse events were:
The most common adverse events reported in the initiation of Strattera therapy were somnolence, dizziness, somnolence, hyperreflexia, and syncope. The most common adverse events reported in patients with a history of cardiovascular disease were hypotension, syncope, and myocardial infarction.
The most commonly reported adverse events reported in patients with a history of depression were somnolence, headache, dizziness, somnolence, dizziness, somnolence, and sleepiness. The most common adverse events reported in patients with a history of Parkinson's disease were headache, dizziness, and vertigo. The most common adverse events reported in patients with Parkinson's disease were somnolence, dizziness, somnolence, dizziness, somnolence, and sleepiness. The most common adverse events reported in patients with schizophrenia were headache, dizziness, and somnolence. The most common adverse events reported in patients with schizophrenia were somnolence, dizziness, somnolence, and sleepiness.
Strattera is a medication approved by the U. S. Food and Drug Administration (FDA) for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD), also known as Hyperactivity Disorder. It is a non-stimulant medication, which has been used for several decades to help treat ADHD. In this blog post, we will discuss the details and how Strattera is used to treat ADHD.
The mechanism of Strattera is to block the effect of a chemical messenger in the brain called a neurotransmitter called D2 dopamine in the brain. D2 dopamine is responsible for the regulation of attention, focus, and impulse control.
A neurotransmitter called norepinephrine has the job of getting to the root of ADHD, while a brain chemical called dopamine has the job of getting to the root of ADHD. This leads to increased attention, focus, and impulsivity in the brain.
Strattera, like any medication, comes with a few side effects. Common ones include:
Strattera can also cause other side effects, such as:
In addition to those side effects, some of the more severe ones include:
Other symptoms may include:
These side effects can be severe and should be discussed with your doctor. If you have any of these symptoms, you should contact your doctor immediately.
Both Strattera and Strattera-XL are used to treat ADHD and help to reduce the amount of medication in the body. However, both are non-stimulant medications that are prescribed to treat ADHD in children and adults. They may not be as effective as stimulant medications in treating ADHD, but they work well to help the body work better.
If you are using both Strattera and Strattera-XL, your doctor will prescribe the drug for you based on your child’s age, weight, and other medications that may be used to treat ADHD. It is important to follow the doctor’s instructions and not to take them with other medications.
Both Strattera and Strattera-XL are non-stimulant medications for the treatment of ADHD. They work in the same way to help with ADHD, but they work differently.
In a study comparing Strattera to Strattera-XL, both the brand and generic versions of Adderall were shown to be effective. However, the study found that the generic Adderall was more effective than the brand version, whereas the brand version was found to be more effective than the generic Adderall.
However, Adderall is not a controlled substance, and its effects are not regulated by the FDA. It is a prescription drug, and doctors are not permitted to prescribe it to children under the age of 18. However, this may not be true for individuals over the age of 18.
It is important to note that these medications may not be suitable for everyone. They should only be used under the supervision of a healthcare professional and under the care of a qualified health provider.
Stade de France Pharmacy